This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Scandion Oncology Gestione
Gestione criteri di controllo 0/4
Informazioni chiave
Bo Hansen
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 1.8yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | less than a year |
| Durata media del Consiglio di amministrazione | 1.2yrs |
Aggiornamenti recenti sulla gestione
Nessun aggiornamento
Recent updates
Nessun aggiornamento
AMMINISTRATORE DELEGATO
Bo Hansen
1.8yrs
Mandato
Dr. Bo Rode Hansen, Msc, Ph D, serves as Vice President of Alliance Management & Partnered Drug Discovery at Roche Innovation Center Copenhagen A/S. Dr. Hansen serves as Director at Scandion Oncology A/S s...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Scientific Advisor | no data | Nessun dato | Nessun dato | |
| President | 1.8yrs | Nessun dato | 0.10% DKK 250.4k | |
| Chief Financial Officer | less than a year | Nessun dato | 0.025% DKK 59.0k | |
| COO and Head of R&D Operations | 1.3yrs | Nessun dato | 0.059% DKK 141.6k | |
| General Counsel | no data | Nessun dato | Nessun dato | |
| Head of External Communication | less than a year | Nessun dato | Nessun dato | |
| Chief Clinical Officer & Employee Representative Director | less than a year | Nessun dato | 0.049% DKK 118.0k | |
| Chief Medical Officer | less than a year | Nessun dato | Nessun dato |
0.7yrs
Durata media
Gestione esperta: SCOL BTA's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Scientific Advisor | 1.3yrs | Nessun dato | Nessun dato | |
| President | 2.2yrs | Nessun dato | 0.10% DKK 250.4k | |
| Chief Clinical Officer & Employee Representative Director | 2.5yrs | Nessun dato | 0.049% DKK 118.0k | |
| Independent Vice-Chairman of the Board | 4.5yrs | Nessun dato | 1.05% DKK 2.5m | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | 1.3yrs | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | less than a year | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | less than a year | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Member of Clinical Advisory Board | less than a year | Nessun dato | Nessun dato | |
| Independent Chairman of the Board | 1.2yrs | Nessun dato | 0.012% DKK 27.7k |
1.2yrs
Durata media
64.5yo
Età media
Consiglio di amministrazione esperto: SCOL BTA's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.